Selective targeting of epigenetic reader domains
Author:
Funder
Deutsche Forschungsgemeinschaft
Else Kröner-Fresenius-Stiftung
European Research Council
Publisher
Informa UK Limited
Subject
Drug Discovery
Link
https://www.tandfonline.com/doi/pdf/10.1080/17460441.2017.1303474
Reference106 articles.
1. Epigenetic protein families: a new frontier for drug discovery
2. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
3. Targeting the cancer epigenome for therapy
4. Open access chemical probes for epigenetic targets
5. The art of the chemical probe
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Post-translational histone modifications associated with the development of metabolic dysfunction-associated fatty liver disease. Part 1. General provisions;GASTROENTEROLOGY;2024-09-13
2. Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor;Journal of Medicinal Chemistry;2024-03-27
3. Targeting Epigenetic Readers Using Small Molecule Binders and PROTAC Degraders;Interdisciplinary Cancer Research;2024
4. GSK2801 Reverses Paclitaxel Resistance in Anaplastic Thyroid Cancer Cell Lines through MYCN Downregulation;International Journal of Molecular Sciences;2023-03-22
5. Structural and Biochemical Analysis of Histone H3.1 Recognition Mechanisms by Tonsuku;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3